Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Anne Stehley who wrote (471)	12/6/1997 11:19:00 AM
From: Doug Bean	Read Replies (2) \| Respond to of 1837

ANNE: I very much agree. Estrogen- Safe estrogen is extremely important , as is estrogen at 1/3 to 1/2 the price it is now. The problem with DRMDs estrogen is that it has to fight a very stacked deck in that American Home has tremendous influence, not only with congress but with medical suppliers/distributors and specifiers. If you have the time read back on this thread to this late summer and fall. There are some good theories about how tough it will be for them. Don't get me wrong I WANT DRMD to have great trials and get approval for their Conjugated estrogen, but I think the big bang there will come when they get approval ,, after that its all up hill. As far as being in it till then, hey here I am and here I will stay . If they put the stock "on sale" i will continue to buy too. CRDoug